annual cash & cash equivalents:
$681.10M+$305.17M(+81.18%)Summary
- As of today (September 14, 2025), BBIO annual cash & cash equivalents is $681.10 million, with the most recent change of +$305.17 million (+81.18%) on December 31, 2024.
- During the last 3 years, BBIO annual cash & cash equivalents has risen by +$287.33 million (+72.97%).
- BBIO annual cash & cash equivalents is now at all-time high.
Performance
BBIO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$757.34M+$216.62M(+40.06%)Summary
- As of today (September 14, 2025), BBIO quarterly cash & cash equivalents is $757.34 million, with the most recent change of +$216.62 million (+40.06%) on June 30, 2025.
- Over the past year, BBIO quarterly cash & cash equivalents has increased by +$170.16 million (+28.98%).
- BBIO quarterly cash & cash equivalents is now -17.61% below its all-time high of $919.26 million, reached on March 31, 2021.
Performance
BBIO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BBIO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +81.2% | +29.0% |
| 3 y3 years | +73.0% | +5.8% |
| 5 y5 years | +87.2% | -9.9% |
BBIO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +81.2% | at high | +87.6% |
| 5 y | 5-year | at high | +91.3% | -17.6% | +87.6% |
| alltime | all time | at high | +640.4% | -17.6% | +157.8% |
BBIO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $757.34M(+40.1%) |
| Mar 2025 | - | $540.73M(-20.6%) |
| Dec 2024 | $681.10M(+81.2%) | $681.23M(+67.9%) |
| Sep 2024 | - | $405.73M(-30.9%) |
| Jun 2024 | - | $587.18M(+13.0%) |
| Mar 2024 | - | $519.82M(+15.1%) |
| Dec 2023 | $375.94M(-0.2%) | $451.54M(-19.4%) |
| Sep 2023 | - | $559.92M(+38.7%) |
| Jun 2023 | - | $403.72M(-21.9%) |
| Mar 2023 | - | $516.80M(+1.4%) |
| Dec 2022 | $376.69M(-4.3%) | $509.85M(-13.9%) |
| Sep 2022 | - | $592.12M(-17.3%) |
| Jun 2022 | - | $715.85M(+6.6%) |
| Mar 2022 | - | $671.40M(-19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $393.77M(+10.6%) | $836.84M(+39.5%) |
| Sep 2021 | - | $599.79M(-28.4%) |
| Jun 2021 | - | $837.84M(-8.9%) |
| Mar 2021 | - | $919.26M(+51.4%) |
| Dec 2020 | $356.08M(-2.1%) | $607.09M(-14.6%) |
| Sep 2020 | - | $710.68M(-15.5%) |
| Jun 2020 | - | $840.94M(-7.1%) |
| Mar 2020 | - | $905.17M(+65.8%) |
| Dec 2019 | $363.77M(-16.6%) | $545.99M(+1.9%) |
| Sep 2019 | - | $536.05M(+82.5%) |
| Jun 2019 | - | $293.80M(-21.2%) |
| Mar 2019 | - | $373.03M(-14.5%) |
| Dec 2018 | $436.09M(+374.0%) | $436.09M |
| Dec 2017 | $92.00M | - |
FAQ
- What is BridgeBio Pharma, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual cash & cash equivalents year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly cash & cash equivalents year-on-year change?
What is BridgeBio Pharma, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of BBIO is $681.10M
What is the all time high annual cash & cash equivalents for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual cash & cash equivalents is $681.10M
What is BridgeBio Pharma, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, BBIO annual cash & cash equivalents has changed by +$305.17M (+81.18%)
What is BridgeBio Pharma, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BBIO is $757.34M
What is the all time high quarterly cash & cash equivalents for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly cash & cash equivalents is $919.26M
What is BridgeBio Pharma, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, BBIO quarterly cash & cash equivalents has changed by +$170.16M (+28.98%)